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Abstract
Focal Adhesion Kinase (FAK) is a non-receptor tyrosine kinase that plays a key role in cellular
processes such as cell adhesion, migration, proliferation and survival. Recent studies have also
implicated FAK in the regulation of cell-cell adhesion. Here, evidence is presented showing that
siRNA-mediated suppression of FAK levels in NBT-II cells and expression of dominant negative
mutants of FAK caused loss of epithelial cell morphology and inhibited the formation of cell-cell
adhesions. Rac and Rho have been implicated in the regulation of cell-cell adhesions and can be
regulated by FAK signaling. Expression of active Rac or Rho in NBT-II cells disrupted formation
of cell-cell contacts, thus promoting a phenotype similar to FAK-depleted cells. The loss of
intercellular contacts in FAK-depleted cells is prevented upon expression of a dominant negative
Rho mutant, but not a dominant negative Rac mutant. Inhibition of FAK decreased tyrosine
phosphorylation of p190RhoGAP and elevated the level of GTP-bound Rho. This suggests that FAK
regulates cell-cell contact formation by regulation of Rho.
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The regulation of cell adhesion, both with the extracellular matrix and between cells, is
fundamental to a number of biological properties including cell migration and the maintenance
of tissue architecture. The establishment of cell-cell contacts in epithelial cells is mediated by
a transmembrane family of proteins called the cadherins, of which E-, P-, VE- and N-cadherin
are members. In the presence of calcium, homophilic interactions occur between the
extracellular domains of cadherins expressed on the lateral membrane domains of adjacent
cells. The cytoplasmic domain of the cadherins establishes a linkage to the actin cytoskeleton
by binding to multiple actin-binding proteins including α-catenin, the tight junction component
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ZO-1 and a component of focal adhesions, vinculin [1]. These sites of cell-cell contact
containing cadherins are termed adherens junctions. The importance of cadherin-mediated
cellular contacts in the differentiated phenotype and other functions such as an environmental
barrier has been well established [2].
Dramatic changes in the actin cytoskeleton occur upon cell-cell adhesion suggesting a role for
the Rho family of GTPases in regulating junction assembly. Indeed, the activity of RhoA and
Rac is required for the formation and maintenance of cadherin dependent cell-cell contacts
[3-5]. However, the activity of these GTPases must be properly regulated as constitutive
activation of RhoA and Rac can impair junction assembly and/or disrupt cell-cell contacts in
some scenarios [3,6,7]. Interestingly, one stimulus that triggers activation of Rac is the
homophilic interaction between E-cadherins on adjacent cells [8-11]. In some cell types this
also triggers Cdc42 activation, but notably homophilic E-cadherin interactions cause a
reduction in the activation of RhoA. The activation of Rac at an early stage of nascent cell-cell
contacts is regulated via a signaling pathway containing c-Src, Rap and PI3-kinase culminating
in activation of the guanine nucleotide exchange factor, Vav2 [12,13]. In contrast, RhoA
activity is regulated via a GTPase activating protein, p190RhoGAP, which becomes tyrosine
phosphorylated and activated upon E-cadherin ligation [8,9]. Presumably the regulation of Rac
and RhoA upon homophilic E-cadherin interactions is a feedback mechanism to promote
strengthening of the adhesion following initial contact.
FAK is a focal adhesion-associated protein tyrosine kinase that transmits signals downstream
of integrins and is a well established as a regulator of the actin cytoskeleton and cell motility
[14]. FAK-mediated effects on the actin cytoskeleton occur via regulation of Rho family
GTPases. FAK apparently activates Rac via the p130Cas adaptor protein. Tyrosine
phosphorylation of p130Cas recruits into complex the Crk adaptor protein, which binds the
Dock180/Elmo complex. These function as a RacGEF promoting the activation of Rac
[15-17]. Rho is also regulated by FAK [18]. Fak-/- fibroblasts exhibit a Rho-dependent
phenotype, i.e. large focal adhesions [19]. Inhibition of Rho reverts the phenotype of the focal
adhesions of fak-/- cells to wild-type, whereas introduction of active Rho into normal fibroblasts
induces a focal adhesion morphology resembling fak-/- cells [18]. Upon cell adhesion to
fibronectin, fibroblasts exhibit a transient reduction in the activity of Rho. Under similar
conditions fak-/- fibroblasts exhibit no reduction in Rho activity [18]. This suppression of Rho
activity has been linked to tyrosine phosphorylation and activation of p190RhoGAP [20],
suggesting FAK might regulate Rho activity through this mechanism. FAK might also regulate
Rho activity through an associated Rho GAP called GRAF and p190RhoGEF, which binds to
the C-terminal domain of FAK [21,22]. These studies demonstrate that FAK utilizes multiple
mechanisms to regulate the activity of Rho family GTPases.
A role for FAK in the regulation of cell-cell contacts is beginning to emerge. Firstly, elevated
Src activity in KM12C colon cancer cells was found to inhibit adherens junction assembly
[23]. Normal junction assembly could be restored in cells expressing a FAK mutant lacking
all Src-dependent phosphorylation sites [23]. This suggests that FAK functions downstream
of activated Src to impair the formation of adherens junctions and may promote EMT
(epithelial-mesenchymal transition). Secondly, depletion of FAK from Hela cells impairs the
formation of N-cadherin-mediated cell-cell contacts and increases cell protrusiveness [24].
This phenotype is dependent on cell density. In confluent cultures, where cell protrusions
cannot form, the loss of FAK did not affect the presence of cell-cell contacts. In subconfluent
cultures, where cells may form cellular protrusions and migrate, N-cadherin mediated cell-cell
contacts are lost in FAK depleted cells [24]. Thus in different scenarios, FAK may promote
the formation of cell-cell contacts and control the disassembly of cell-cell junctions. To further
explore the role of FAK in regulation of cell-cell junctions, activated FAK was expressed in
NBT-II rat bladder adenocarcinoma cells, which are an attractive model for the study of EMT
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[25]. Expression of an activated form of FAK did not induce EMT as adherens junction
disassembly was not observed. However, in cells expressing a kinase inactive form of FAK,
cell-cell adhesions were vastly diminished. This observation suggested that the activity of FAK
may be important for the formation/stabilization of intercellular adhesions and prompted
further investigation of FAK function in the assembly of cell-cell junctions.
MATERIALS AND METHODS
Cell culture and transfection
NBT-II were maintained in Dulbecco’s modified Eagle’s medium containing 10% Fetal Bovine
Serum (FBS). GFP/YFP-fusion constructs were transfected into cells using LipofectAMINE™
Plus (Invitrogen) following the manufacturer’s recommended protocol. FAK expression was
inhibited using RNA interference technology [26]. The FAK siRNA target sequence was 5′-
AAGAUUACCAAUGCCUCCAAA-3′. Both FAK and control #1 siRNA duplexes were
purchased from Dharmacon. Duplexes were transfected into cells using Oligofectamine™
(Invitrogen) following the manufacturer’s instructions. Routinely, 2 × 105 cells were
transfected with 200 nM siRNA in a 6-well tissue culture dish. For retroviral infection of NBT-
II cells, avian SuperFAK (a FAK variant with activation loop point mutations that elevate
catalytic activity [27]) and kinase-inactive SuperFAK (K454M) were subcloned into a
modified retroviral bicistronic GFP vector, MIGR1 [28]. Retroviruses encoding SuperFAK,
SuperFAK K454M and vector alone were introduced into NBT-II cells. GFP-positive cells
were selected by FACs cell sorting. Experiments were performed using cells at passage 8 or
less.
Molecular Biology
Plasmids encoding GFP fusion proteins of active Rac (Q61L) and dominant negative Rac (N17)
have been previously described [29]. Active Rho (Q63L) and dominant negative Rho (N19)
were amplified by PCR and subcloned into pEYFP-C1 in frame with the YFP coding sequence.
The FERM domain of FAK was amplified by PCR and subcloned into pEYFPc1 in frame with
YFP. GFP-FAK has been described previously [30]. Point mutations were engineered into
GFP-FAK using the QuikChange strategy (Stratagene, La Jolla CA). Sequence analysis was
performed on each mutant to verify the intended point mutations/deletions and that no
unintended mutations were present. These analyses were performed in the UNC-CH Genome
Analysis Facility on a model 3730 DNA Analyzer (Perkin Elmer, Applied Biosystems
Division) using the ABI PRISM™ Dye Terminator Cycle Sequencing Ready Reaction Kit with
AmpliTaq DNA Polymerase, FS (Perkin Elmer, Applied Biosystems Division).
Fluorescence Microscopy
NBT-II were fixed in 3.7% formaldehyde prepared in phosphate-buffered saline (PBS) for 10
minutes, followed by permeabilization with PBS containing 0.25% Triton-X-100 for 5 minutes.
The slides were blocked in PBS containing 3% BSA for 1 hour at 37°C. Samples were stained
with an E-cadherin antibody (1:200 BD Biosciences) by incubation overnight at 4°C.
Alternatively, junctions were visualized by staining with a β-catenin antibody (1:200 BD
Biosciences). Primary antibody was visualized by incubation with rhodamine-conjugated anti-
mouse immunoglobulin G (1:200) for 1 hour at 37°C. Endogenous FAK was detected by
immunostaining with the 4.4.7 monoclonal antibody (Upstate Biotechnology), a rabbit anti-
mouse secondary and a donkey anti-rabbit tertiary antibody conjugated to fluorescein.
Phosphorylated FAK was detected by immunostaining with the PY397 phospho-specific
antibody (Biosource International). The cells were mounted in a mixture of 10% Tris pH 7.5,
90% glycerol, and 25 mg/ml 1,4-diazabicyclo (2,2,2) octane (DABCO) (Sigma, St Louis MO).
Confocal microscopy was performed on Leica SP2 AOBS confocal laser scanning microscope
at 63x magnification.
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Cells were lysed in 1% Triton X-100 lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl,
10% glycerol, 1% Triton X-100) or 0.2% Triton X-100 lysis buffer (0.2% triton, 0.3 M sucrose,
50 mM Tris-HCl (pH 7.5), 100 mM KCl, 1 mM CaCl2, 2.5 mM MgCl2) containing protease
and phosphatase inhibitors and the protein concentration determined using the bicinchoninic
acid assay (Pierce, Rockford IL). Immunoprecipitations were performed using 1 mg of protein
lysate and 15 μl of FAK (BC4) polyclonal antiserum [30]. Immune complexes were
precipitated using protein A Sepharose beads. The beads were washed three times in lysis
buffer and boiled in sample buffer. Immune complexes and were analyzed by Western blotting
using the following antibodies; FAK (clone 4.47 1:1000, Upstate Biotechnology), phospho-
FAK Y861, phospho-FAK Y397, phospho-FAK Y407 (all 1:500, Biosource International) and
visualized using secondary antibodies conjugated to horseradish peroxidase and enhanced
chemiluminescence. To confirm equal loading for Western blotting, antibodies against E-
cadherin (1:1000), ERK1 (1:1000, Santa Cruz Biotechnology) or actin (1:1000-Chemicon)
were used. The Rho activity assay was performed as previously described [31].
RESULTS
Inhibition of FAK inhibits E-cadherin mediated cell-cell contact formation
To further investigate the role of FAK in controlling cell-cell junctions an activated form of
FAK (SuperFAK) and a catalytically inactive variant (SuperFAK K454M) were moderately
overexpressed in NBT-II cells (Fig. 1A). Confluent cultures were treated with 2 mM EGTA
for two hours to remove extracellular calcium. Under these conditions, interactions between
cadherins on opposing cells are lost and the cells lack E-cadherin at the cell periphery (Fig.
1B, top row). Restoration of 2 mM calcium to the growth media for four hours allows
reassembly of cell-cell junctions and E-cadherin becomes localized to cell-cell contacts. This
was observed in both the vector expressing control cells and in SuperFAK expressing cells
(Fig. 1B, second row). In contrast, SuperFAK K454M expressing cells exhibited only the initial
stages of cell-cell contact, where cell protrusions from one cell contact a neighboring cell and
diffuse localization of E-cadherin is observed (Fig. 1B, second row). Twenty-four hours after
calcium addition, the cell-cell contacts formed by control cells, SuperFAK expressing cells
and SuperFAK K454M expressing cells were similar (Fig. 1B, bottom row). This indicated
that expression of SuperFAK K454M induced a delay and not a complete block of the assembly
of cell-cell adhesions. SuperFAK K454M may be acting as a dominant-negative mutant to
inhibit endogenous FAK and impairing nascent cell-cell contact formation in NBT-II cells.
The ability of other mutants of FAK to inhibit the formation of cell-cell contacts was addressed
by transient expression of GFP fusion proteins in NBT-II cells. Forty-eight hours post
transfection, the cells were subjected to the calcium switch protocol and cell-cell contacts were
visualized by immunofluorescence using an E-cadherin or β-catenin antibody. Transfected
cells were identified as GFP-positive. Expression of GFP alone or GFP-FAK had no
detrimental effect on the formation of cell-cell contacts (Fig. 1C and D). Similarly, contact
formation was unaffected in cells expressing a mutant of FAK, where tyrosine residue 861 is
replaced with phenylalanine (Fig. 1C). However, many cells expressing GFP-FAK Y397F
lacked typical epithelial morphology and intercellular contacts, and the cells appeared more
spread (Fig. 1C). Similarly, cells expressing an established dominant negative mutant of FAK,
GFP-FRNK, also exhibited impaired junction formation under these conditions with an
apparent increase in cytosolic β-catenin (Fig 1D). Expression of the N-terminal FERM domain
of FAK fused to YFP had no effect upon the formation of E-cadherin positive, cell-cell
junctions following the calcium switch (data not shown). The proportion of GFP-positive cells
exhibiting E-cadherin localization at points of contact between opposing cells was quantified
(Fig. 1E). Whereas over 90% of GFP or GFP-FAK expressing cells exhibited E-cadherin
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localization at cell-cell contacts, fewer than 45% of cells expressing GFP-FRNK or GFP-FAK
Y397F showed similar E-cadherin localization (Fig. 1E). GFP-FAK Y861F, GFP-FAK Y407F
and YFP-FERM expressing cells exhibited no significant difference in the formation of E-
cadherin positive cell-cell contacts relative to GFP expressing control cells. Taken together,
FAK kinase activity and tyrosine 397 are important for the formation of cell-cell contacts in
NBT-II cells.
The observation that mutants of FAK can disrupt cell-cell contacts, suggested that FAK plays
an important role in the maintenance of the epithelial phenotype. To further substantiate these
claims, FAK-specific small interfering RNA duplexes were transfected into NBT-II cells. The
effect of FAK depletion on formation of cell-cell contacts was assessed. Routinely, over 70%
suppression of FAK protein levels was achieved at seventy hours post-transfection (Fig. 2A,
top row, lane 2). ERK and E-cadherin expression levels were unaltered (Fig. 2A, row 2 and
3). At seventy-two hours post-transfection, cells were plated to approximately 50% confluence
and subjected to calcium switch. Two hours after calcium restoration, approximately 41% of
cells transfected with control siRNA formed cell-cell contacts (Fig. 2B, left panel and Fig. 2C).
In contrast, FAK-depleted cells exhibited loss of epithelial cell morphology, and lacked cell-
cell contacts in all but 15% of cells (Fig. 2B, middle panel and Fig. 2C). This phenotype
resembled NBT-II cells transfected with FRNK or FAK Y397F as described above.
The FAK siRNA used for these experiments was specific for rat, mouse and human, but not
avian FAK. Stable NBT-II cells expressing avian FAK and control cells containing empty
vector were generated to test whether the phenotype observed in cells lacking endogenous FAK
could be rescued by re-expression of FAK. NBT-II avian-FAK cells continued to express FAK
even upon treatment with the FAK siRNA targeting the endogenous rat FAK (Fig. 2A, top
panel, lane 3). Furthermore, NBT-II-avian FAK cells treated with FAK siRNA exhibited E-
cadherin positive contacts in approximately 52% of the cells following calcium switch (Fig.
2B, right panel and Fig. 2C). This proportion was not statistically different from vector
containing NBT-II cells treated with control siRNA (Fig. 2C). In addition, most NBT-II-avian
FAK cells treated with the FAK siRNA retained epithelial cell morphology, in contrast to vector
containing cells treated with the FAK siRNA (Fig. 2B). These findings support a role for FAK
in regulating the assembly of E-cadherin positive cell-cell contacts.
Cell-cell contact formation regulates FAK phosphorylation
The formation of homophilic contacts between cadherin molecules on adjacent cells triggers
activation of cytoplasmic signaling molecules. To assess whether FAK is regulated upon cell-
cell adhesion its tyrosine phosphorylation was monitored during cell-cell interaction following
calcium switch. The cells were lysed at various times, FAK was immunoprecipitated and the
immune complexes immunoblotted for phospho-FAK 407 and phospho-FAK 861 (Fig. 3).
Alternatively, cell lysates were directly blotted using phosphospecific antibodies recognizing
FAK tyrosine residues 397, 576, 577 and 925. Little or no change in the level of phosphorylation
of most of these residues relative to untreated confluent cultures was detected (Fig. 3 A and
C). However, elevated phosphorylation of tyrosine 861 was detected after two-hours of calcium
replenishment (Fig. 3A). Phosphorylation of tyrosine 861 was dependent upon E-cadherin
interactions since the response was blocked in the presence of a function blocking E-cadherin
antibody (Fig. 3B).
Previous studies have suggested that FAK can localize at sites of cell-cell contact in several
cell types [32,33]. In confluent cultures of NBT-II cells, GFP-FAK constructs did not localize
to cell-cell contacts, however during the reassembly of junctions following calcium switch
these constructs could be detected at a low frequency at cell junctions (data not shown). The
localization of endogenous FAK following calcium switch was examined by
immunofluorescence. A small fraction of endogenous FAK was localized to cell-cell junctions
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(Fig. 3D, panels ii and iii). This staining was specific, since it was not observed in
immunofluorescence controls (Fig. 3D, panel i). Interestingly, the phospho-specific antibody
recognizing PY397 weakly immunostained cell-cell junctions in NBT-II cells following
calcium switch, suggesting that the population of FAK recruited to this site was phosphorylated
at tyrosine 397 (Fig. 3E). This could be significant since tyrosine 397 is a critical
phosphorylation site in FAK and expression of the FAK 397F mutant blocks junction
formation.
FAK regulation of cell-cell contact formation: role of Rho proteins
Both Rho and Rac are downstream targets of FAK signaling upon adhesion to the extracellular
matrix. Furthermore, the activity of both Rho and Rac are altered upon cadherin signaling, and
each has been implicated in regulating adherens junction formation. To validate the role of
Rho and Rac in the formation of E-cadherin positive cell-cell contacts in NBT-II cells,
constitutively active and inactive forms of both GTPases (Rho Q63L/N19 and Rac Q61L/N17)
were transiently expressed as YFP and GFP fusion proteins. Forty-eight hours post-transfection
the cells were subjected to a two-hour calcium switch. The cells were stained for E-cadherin
to identify cell-cell contacts and Rho GTPase expressing cells were identified as GFP- or YFP-
positive by fluorescent microscopy (Fig. 4A). GFP-Rac N17 and YFP-Rho N19 expressing
cells formed E-cadherin positive cell-cell contacts as well as control cells (Fig. 4A first and
third rows). Quantification revealed that greater than 82% of cells expressing GFP-RacN17,
YFP-RhoN19 or GFP alone formed E-cadherin positive cell-cell contacts (Fig. 4B). In contrast,
most cells expressing GFP-Rac Q61L or YFP-Rho Q63L were devoid of intercellular contacts
and exhibited a loss of epithelial cell morphology (Fig. 4A row 2 and 4). Only 28 and 35% of
cells expressing activated Rac and Rho respectively contained E-cadherin positive cell-cell
contacts (Fig. 4B). This result is consistent with the literature describing a detrimental effect
of expression of constitutively activated Rac and Rho upon the formation of cell-cell junctions
[3,6,7]. Further, this phenotype resembled that of NBT-II cells with suppressed FAK
expression or expressing dominant negative FAK mutants.
Given that active Rac and Rho induced a phenotype similar to suppression of FAK expression
in NBT-II cells, the effect of inhibiting Rac or Rho in NBT-II cells with suppressed FAK
expression was assessed. Populations of NBT-II cells stably expressing GFP, GFP-avian FAK,
GFP-RacN17 and YFP-RhoN19 were generated. These cells were transfected with FAK
siRNA and 72 hours post-transfection the cells were subjected to a calcium switch and the
reformation of cell-cell contacts quantified. Approximately 33% of vector expressing cells
transfected with FAK siRNA exhibited E-cadherin positive cell-cell contacts (Fig. 5A). This
defect was rescued by re-expression of FAK since FAK depleted cells expressing GFP-avian
FAK exhibited E-cadherin positive cell-cell contacts in approximately 79% of the cells. A
similar proportion of GFP-RacN17- and GFP-expressing cells transfected with FAK siRNA
exhibited E-cadherin positive cell-cell contacts (Fig. 5A). This suggested that inhibition of Rac
with this dominant-negative mutant could not prevent the defect in cell-cell contact formation
observed in FAK deficient cells. In contrast, this cell-cell contact defect was rescued by
expression of a dominant negative Rho mutant. Approximately 80% of the YFP-RhoN19
expressing, FAK siRNA treated cells exhibited E-cadherin positive cell-cell contacts (Fig. 5A).
This observation suggested that dominant negative Rho could prevent the loss of epithelial
cell-cell contacts in cells where FAK signaling is impaired. This finding is consistent with the
observation that Rho activity is elevated in fak-/- fibroblasts [18]. To validate that inhibition of
FAK function resulted in increased Rho activity in NBT-II cells, the amount of GTP-bound
Rho was measured using an effector pulldown assay [31]. NBT-II cells exhibited low Rho
activity under low calcium conditions, which increased by two hours following the addition
of calcium (Fig. 5B). In contrast, cells expressing FRNK exhibited higher levels of Rho activity
under low calcium conditions and following the addition of calcium (Fig. 5B). The level of
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active Rho from multiple experiments was quantified by Image J analysis. While FRNK
expressing cells exhibited a reproducible increase in Rho activity under these conditions, the
increase did not reach statistical significance (Fig. 5C). Therefore FAK’s affect upon total
cellular Rho activity was modest. To further explore the role of FAK in Rho regulation, the
effect of inhibiting FAK expression upon established Rho regulatory proteins was assessed.
One potential regulatory mechanism is via regulation of p190RhoGAP. Tyrosine
phosphorylation of RhoGAP results in its activation and consequently a reduction in the level
of active Rho. Tyrosine phosphorylation of p190RhoGAP in control and FAK siRNA
transfected NBT-II cells was compared by immunoprecipitation and Western blotting.
Knockdown of FAK expression reduced p190RhoGAP tyrosine phosphorylation suggesting
that this mechanism of regulation might be operative in NBT-II cells (Fig. 5D).
DISCUSSION
In this study disruption of endogenous FAK using several different strategies resulted in
impaired cell-cell junction formation. These findings demonstrate that endogenous FAK
functions in regulating the assembly of E-cadherin containing junctions in NBT-II cells. In
addition, FAK was shown to localize to sites of cell-cell contact. This likely represents a
transient association, since only ∼10% of cell contacts contained detectable FAK by
immunofluorescence and FAK was not detected in the cell-cell junctions in confluent cultures
of NBT-II cells. Insight into the mechanism through which FAK regulates cell-cell adhesions
in NBT-II cells was also obtained. Inhibition of FAK resulted in reduced phosphorylation of
p190RhoGAP and a modest elevation in total Rho activity. Since inhibition of Rho signaling
rescues the effect of FAK suppression on cell-cell junction formation, FAK seems to control
cell-cell junction formation in NBT-II cells by regulating Rho activity.
The association of FAK with cell-cell junctions is intriguing. A recent finding also suggests
that FAK localizes to cell-cell contact sites in the Panc-1 pancreatic cancer cell line when the
cells are plated on collagen [33]. FAK is reported to interact with a number of transmembrane
tyrosine kinase receptors including Met, PDGFR and EGFR [34-36]. As EGFR has been shown
to localize at sites of cell-cell contact FAK might be recruited to these sites through interaction
with this receptor tyrosine kinase [37]. FAK also associates with integrins and integrins have
been localized to sites of cell-cell contact in some cell types, including several epithelial cell
lines [38-41]. In fact, oligomerized E-cadherin may serve as a ligand for some integrins, e.g.
α2β1 [42]. Hence, it is plausible that FAK may be recruited to cell-cell contact sites via integrins
which are localized to the adherens junction complex. FAK is reported to associate with E-
cadherin in Panc-1 cells [33], and to associate with α- and β-catenin in normal cervical tissue
and cervical carcinomas [43]. While these are potential mechanisms of localization, we have
been unable to demonstrate specific interactions between full length FAK and E-cadherin or
α-/β-catenin in NBT-II cells by co-immunoprecipitation (data not shown).
While phosphorylation of other tyrosine residues did not change appreciably, Y861 did become
strikingly phosphorylated upon the formation of cell-cell contacts in NBT-II cells. Elevated
Y861 phosphorylation has been observed in Hela cells plated on collagen [24]. Under these
conditions HeLa cells form N-cadherin positive cell-cell contacts and the formation of these
contacts is impaired in cells treated with FAK-specific siRNAs [24]. Re-expression of wild
type FAK restored N-cadherin positive cell-cell adhesions, but re-expression of a FAK Y861F
mutant failed to rescue the phenotype, implicating Y861 phosphorylation in the control of
junction assembly. In our study, exogenous expression of the Y861F mutant had no detrimental
effect on formation of cell-cell contacts, in contrast to expression of other dominant negative
mutants of FAK. Further, expression of the Y861F mutant was able to rescue the cell-cell
junction defect induced by FAK siRNA (data not shown). Thus, Y861 phosphorylation was
not required to promote E-cadherin positive cell-cell junctions in NBT-II cells. The difference
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between these studies may be explained by the use of different cell types, different extracellular
matrix proteins or unique mechanisms of regulation of cell-cell contacts containing different
cadherins.
Expression of FAK Y397F in NBT-II cells induced a dramatic change of epithelial polarity
and impaired cell-cell contact formation following calcium switch. This suggests
phosphorylation of Y397 is required to promote cell-cell contact formation, a conclusion that
is supported by the findings of Yano et al. [24]. However, in response to the calcium switch in
NBT-II cells, very modest changes in Y397 phosphorylation occurred. There are two possible
explanations to reconcile these observations. Either E-cadherin dependent adhesion promotes
phosphorylation at Y397 in a small fraction of the total cellular FAK or cell-extracellular matrix
adhesion provides sufficient autophosphorylated FAK to function in regulating cell-cell
adhesion. In either event it appears that some autophosphorylated FAK is recruited to cell-cell
junctions during the calcium switch since junctions exhibit PY397 staining.
Autophosphorylation of FAK-Y397 recruits Src and PI3-kinase into complex [44,45]. Both
Src and PI-3 kinase have been implicated in regulation of cell-cell adhesions. Exogenous
expression of c-Src or activated Src variants in various cell lines, including NBT-II, leads to
the disassembly of cell-cell junctions as EMT is induced [23,46,47]. However, c-Src is
activated upon E-cadherin mediated adhesion and is required for activation of Rac [12]. To
further examine a role for Src, NBT-II cells were treated with the Src inhibitor PP2 and the
cells observed to increase E-cadherin positive cell-cell contacts (data not shown). As this
phenotype is opposite that observed upon inhibition of FAK, the result does not support Src
as a key component downstream of FAK, although the complex role of Src in the assembly/
disassembly of junctions makes it difficult to drawn an absolute conclusion. Inhibition of PI3-
kinase activity causes a decrease in E-cadherin at cell-cell contacts in monolayers of scp2
mouse mammary epithelial cells [12,48]. Hence, it is plausible that the effects on cell-cell
adhesion in cells expressing FAK Y397F may be mediated by lack of PI3-kinase binding.
To further address the downstream signaling pathways by which FAK regulates NBT-II cell-
cell contacts, the Rho family of GTPases was examined since Rho and Rac can regulate cell-
cell adhesions and are components of FAK signaling pathways [4,18,24,49]. Expression of
both active Rac and Rho in NBT-II cells increased the frequency of cells lacking E-cadherin
positive cell-cell contacts, a phenotype resembling that of cells with suppressed levels of FAK.
Subsequent experiments indicated that dominant negative Rho, prevents the defect in
intercellular contact formation observed in cells with suppressed FAK expression and cells
expressing FRNK exhibited elevated levels of Rho activity. This result suggested that FAK
promotes cell-cell contact formation by dampening the activity of Rho. This model is consistent
with previous studies demonstrating the role of FAK in preventing hyperactivation of Rho in
fibroblasts [18]. However, the effect of FAK expression upon Rho activation levels in NBT-
II cells was quite modest. These disparate observations can be reconciled if FAK functions to
regulate Rho activity in a spatially restricted manner, and thus only affects a small fraction of
the total cellular Rho. There is precedent for this hypothesis since FAK regulates Rac activity
in a spatially restricted manner in HeLa cells, which impacts the formation of N-cadherin
containing cell-cell junctions [24]. The mechanism of Rho regulation by FAK is possibly via
phosphorylation and activation of a GTPase activating protein such as p190RhoGAP since
reduced p190RhoGAP tyrosine phosphorylation was observed upon knock down of FAK
expression. A similar mechanism of FAK dependent regulation of Rho via p190RhoGAP in
endothelial cells has been proposed [50]. Interestingly, in HeLa cells FAK suppression
impaired the formation of N-cadherin containing cell-cell contacts and this effect was rescued
by expression of dominant negative Rac, suggesting FAK functioned to impair excessive Rac
signaling [24]. Thus while suppression of FAK expression produced a similar phenotype in
NBT-II and HeLa cells, even to the extent that the defect in each case could be rescued by
plating cells at very high density (data not shown)[24], the molecular mechanisms utilized
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appear distinct. Whether these distinct mechanisms are due to the use of different cells or reflect
different modes of regulation of these two types of cadherins remains to be established.
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Figure 1. FAK is required for the formation of cell-cell contacts
A) Stable NBT-II lines containing vector alone (lane 1), SuperFAK (lane 2) or SuperFAK
K454M (lane 3) were generated by retroviral infection. Protein expression was assessed by
Western blotting with a FAK antibody (top row). An ERK antibody was used to demonstrate
equal loading. B) NBT-II cells containing empty vector, SuperFAK or SuperFAK K454M cells
were grown to confluence, then treated with cell-culture media supplemented with 2mM EGTA
for two-hours to disrupt E-cadherin positive cell-cell contacts (top row). Fresh calcium-
containing media was added and the cells were stained 4 and 24-hours later with an E-cadherin
antibody to mark cell-cell contacts. C) NBT-II cells were transiently transfected with plasmids
encoding GFP fused to FAK (row 1), FAK Y397F (row 2) or FAK Y861F (row 3). Forty-eight
hours later the cells were subjected to a two-hour calcium switch. Expressing cells were
identified as GFP positive cells (right column). Cell-cell contacts were marked by E-cadherin
antibody staining using a rhodamine conjugated secondary antibody (left panels). Asterisks
denote transfected cells. D) NBT-II cells were transiently transfected with plasmids encoding
GFP (top panels) or GFP-FRNK (bottom panels) and analyzed as in C, except cell-cell contacts
were stained with a β-catenin antibody. E) Quantification of the percentage of GFP positive
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cells containing one or more cell-cell contacts. Results shown correspond to at least three
independent experiments (+/−S.E.M) with over 100 GFP positive cells scored per experiment.
The data were analyzed using a one-way analysis of variance (p<0.005) and Dunnett’s multiple
comparison post test (*, p<0.05).
Playford et al. Page 13













Figure 2. Suppression of FAK protein levels impairs cell-cell contact formation in NBT-II cells
A) Stable cell lines containing vector alone (lanes 1 and 2) or expressing avian-FAK (lane 3)
were generated by retroviral infection. These cells were transiently transfected with control
siRNA (lanes 1) or a FAK siRNA targeting the endogenous rat protein (lanes 2 and 3). Note
that avian FAK is resistant to knockdown by this FAK siRNA. Seventy-two hours post
transfection the cells were lysed and blotted for FAK (top row), ERK (middle row) and E-
cadherin (bottom row). B) Seventy-two hours post transfection, vector expressing cells
transfected with control siRNA (control) or transfected with FAK siRNA (control + FAK
siRNA) and avian FAK expressing cells transfected with FAK siRNA (FAK + FAK siRNA)
were subjected to a two-hour calcium switch and stained with an E-cadherin antibody to
identify cell-cell contacts. C) the percentage of cells containing one or more contact sites was
quantified. Results shown correspond to three independent experiments (+/− S.E.M) with over
one hundred cells scored per experiment. The data was analyzed using a one-way ANOVA
(p<0.02) and a Dunnett’s multiple comparison post test (*, p <0.05).
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Figure 3. Formation of nascent cell-cell contacts increases phosphorylation at FAK Y861
NBT-II cells were cultured to confluence. One plate, indicative of untreated conditions, was
lysed (control). The cells were subjected to a calcium switch and lysed at the indicated time
after the re-addition of calcium. A) FAK was immunoprecipiated and the immune complexes
blotted for phospho-FAK Y861 and phospho-FAK Y407. The immunoblot in row 2 was
reprobed with a FAK antibody to demonstrate equal loading. B) Cells were subjected to a
calcium switch in the absence (−) or presence (+) of 5 μg/ml SHE78-7, an E-cadherin function
blocking antibody. Cells were lysed 2 hours after the addition of calcium, FAK was
immunoprecipitated and blotted for PY861 or FAK. C) Equal amounts of cell lysate were
directly blotted for phospho-FAK Y397, phospho-FAK Y576, phospho-FAK 577 and
Playford et al. Page 15













phospho-FAK Y925. Lysates were blotted for FAK as a loading control. D) After calcium
switch, NBT-II cells were stained for endogenous FAK using a monoclonal antibody, a rabbit
anti-mouse secondary antibody and a FITC-labeled donkey anti-rabbit tertiary antibody. Two
examples are shown (panel ii and iii). The controls lack the primary antibody (i). E) Following
calcium switch, NBT-II cells were immunostained to examine the cellular localization of
phospho-FAK Y397. Cells were co-stained with E-cadherin to mark cell-cell contacts.
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Figure 4. Expression of activated Rho (Q63L) or Rac (Q61L) impairs formation of cell-cell contacts
in NBT-II cells
A) NBT-II cells were transiently transfected with the empty pEGFP vector or plasmids
encoding GFP-fusion proteins containing dominant negative/constitutively active Rac (N17/
Q61L) or YFP-fusion proteins containing dominant negative/constitutively active Rho (N19/
Q63L). Forty-eight hours post-transfection the cells were subjected to a two-hour calcium
switch. Expressing cells were identified as GFP positive (left column) and cell-cell contacts
were visualized by staining with an E-cadherin antibody and a rhodamine-conjugated
secondary antibody (right column). The arrows indicate examples of Rac Q61L and RhoQ63L
expressing cells that exhibit loss of cell-cell contacts. B) The proportion of GFP/YFP positive
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cells containing more than one intercellular contact was quantified. Results shown correspond
to at least three independent experiments (+/− S.E.M) with over one hundred GFP/YFP positive
cells scored per experiment. The data were analyzed using a one-way analysis of variance
(p<0.0005) and the Dunnett’s multiple comparison post test (*, p<0.01).
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Figure 5. FAK regulates cell-cell contact formation by inhibition of Rho
A) NBT-II cells stably expressing EGFP (GFP), GFP-avian FAK (FAK), GFP-Rac N17
(RacN17) or YFP-RhoN19 (RhoN19) were generated. These cells were transfected with
control siRNA or FAK siRNA. Seventy-two hours post transfection cells were subjected to a
two-hour calcium switch, and cells stained with an E-cadherin antibody to identify cell-cell
contacts. Cells with E-cadherin positive cell-cell contacts were scored as described above.
Results shown correspond to at least three independent experiments (+/− S.E.M) with over one
hundred GFP/YFP positive cells scored per experiment. The data were analyzed using a one-
way analysis of variance (p<0.001) and the Dunnett’s multiple comparison post test (*, p<0.01).
B) Control cells and GFP-FRNK expressing cells were subjected to calcium switch and lysed
at the indicated times following re-addition of calcium. GTP-bound Rho was identified using
an effector pulldown assay and Western blotting (top panel). Rho expression was examined
by Western blotting equal amounts of lysate (bottom panel). C) Control or FRNK expressing
cells were subjected to calcium switch and at 0, 1 and 2 hours following re-addition of calcium
the cells were lysed. The levels of active Rho was determined as in B. Images were quantified
using ImageJ and the ratio of active Rho/total Rho was determined for each sample. The relative
levels of active Rho, with the level seen in control cells at t=0 normalized to 1, is shown (n=7).
D) NBT-II cells treated with control or FAK siRNA were lysed and p190RhoGAP
immunoprecipitated. Phosphotyrosine was examined by Western blotting (top panel) and the
amount of p190RhoGAP protein determined as a loading control (bottom panel).
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